Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis-Reference-Cited by-同舟云学术

Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis

Published:2015-11-02 Issue:2 Volume:51 Page:277-282
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Riches M L,Trifilio S,Chen M,Ahn K W,Langston A,Lazarus H M,Marks D I,Martino R,Maziarz R T,Papanicolou G A,Wingard J R,Young J-AH,Bennett C L

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2015263.pdf

Reference25 articles.

1. Pasquini M, Zhu X. Current use and outcome of hematopoietic stem cell transplantation. CIBMTR Summary Slides 2014. Available from: http://www.cibmtr.org .

2. Copelan E, Casper JT, Carter SL, van Burik JA, Hurd D, Mendizabal AM et al. A scheme for defining cause of death and its application in the T cell depletion trial. Biol Blood Marrow Transplant 2007; 13: 1469–1476.

3. Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15: 1143–1238.

4. Goodman JL, Winston DJ, Greenfield RA, Chandrasekar PH, Fox B, Kaizer H et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845–851.

5. Marr KA, Carter RA, Crippa F, Wald A, Corey L . Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909–917.

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disseminated fusariosis after allogenic hematopoietic stem cell transplantation: case report;Infection;2024-08-26

2. Invasive fusariosis;Clinical Microbiology Reviews;2023-12-20

3. Part 1: Mucormycosis: prevalence, risk factors, clinical features, and diagnosis;Expert Review of Anti-infective Therapy;2023-06-07

4. Clinical Features and Treatment Progress of Invasive Mucormycosis in Patients with Hematological Malignancies;Journal of Fungi;2023-05-19

5. A case of subacute bowel obstruction revealing slowly-evolutive gastro-intestinal mucormycosis following allogeneic hematopoietic cell transplantation;Journal of Medical Mycology;2022-11